**5. References**

Adams DH, Shaw S (1994) Leucocyte-endothelial interactions and regulation of leucocyte migration. *Lancet* 343(8901): 831-836.

Clark WR, Hamburger RJ, Lysaght MJ (1999) Effect of membrane composition and structure

Cohen G, Horl WH (2009a) Free immunoglobulin light chains as a risk factor in renal and

Cohen G, Horl WH (2009b) Resistin as a cardiovascular and atherosclerotic risk factor and

Cohen G, Haag-Weber M, Horl WH (1997) Immune dysfunction in uremia. *Kidney Int* Suppl

Cohen G, Rudnicki M, Horl WH (2001) Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils. *Kidney Int* Suppl 78: S48-52. Cohen G, Rudnicki M, Deicher R, Horl WH (2003) Immunoglobulin light chains modulate polymorphonuclear leucocyte apoptosis. *Eur J Clin Invest* 33(8): 669-676. Coldren CD, Nick JA, Poch KR, Woolum MD, Fouty BW et al. (2006) Functional and

D'Intini V, Bordoni V, Bolgan I, Bonello M, Brendolan A et al. (2004) Monocyte apoptosis in

Dadfar E, Lundahl J, Jacobson SH (2004a) Monocyte adhesion molecule expression in

Dadfar E, Lundahl J, Jacobson SH (2004b) Granulocyte extravasation and recruitment to

Dadfar E, Jacobson SH, Lundahl J (2007) Newly recruited human monocytes have a

Dadfar E, Lundahl J, Fernvik E, Nopp A, Hylander B et al. (2004c) Leukocyte CD11b and

Dahlgren C, Karlsson A (1999) Respiratory burst in human neutrophils. *J Immunol Methods* 

de Lemos, J. A., D. A. Morrow, et al. (2003) Association between plasma levels of monocyte

Descamps-Latscha B (1993) The immune system in end-stage renal disease. *Curr Opin* 

Drost, E. M. and W. MacNee (2002) Potential role of IL-8, platelet-activating factor and TNF-

Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T et al. (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. *N Engl J Med* 347(25): 2010-2019.

genomic changes induced by alveolar transmigration in human neutrophils. *Am J* 

uremia is normalized with continuous blood purification modalities. *Blood Purif* 

interstitial inflammation in patients with renal failure. *Nephrol Dial Transplant* 19(3):

sites of interstitial inflammation in patients with renal failure. *Am J Nephrol* 24(3):

preserved responsiveness towards bacterial peptides in terms of CD11b upregulation and intracellular hydrogen peroxide production. *Clin Exp Immunol*

CD62l expression in response to interstitial inflammation in CAPD patients. *Perit* 

chemoattractant protein-1 and long-term clinical outcomes in patients with acute

alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis. *Eur J Immunol* 32(2):

extrarenal complications. *Semin Dial* 22(4): 369-372.

*Physiol Lung Cell Mol Physiol* 291(6): L1267-1276.

coronary syndromes. *Circulation* 107(5): 690-5.

*Nephrol Hypertens* 2(6): 883-891.

uremic toxin. *Semin Dial* 22(4): 373-377.

2015.

62: S79-82.

22(1): 9-12.

614-622.

330-339.

148(3): 573-582.

232(1-2): 3-14.

393-403.

*Dial Int* 24(1): 28-36.

on solute removal and biocompatibility in hemodialysis. *Kidney Int* 56(6): 2005-


Adams DH, Lloyd AR (1997) Chemokines: leucocyte recruitment and activation cytokines.

Albelda SM, Smith CW, Ward PA (1994) Adhesion molecules and inflammatory injury.

Allon M, Depner TA, Radeva M, Bailey J, Beddhu S et al. (2003) Impact of dialysis dose and

Bainton DF, Miller LJ, Kishimoto TK, Springer TA (1987) Leukocyte adhesion receptors are

Bloembergen WE, Port FK (1996) Epidemiological perspective on infections in chronic

Bordoni V, Piroddi M, Galli F, de Cal M, Bonello M et al. (2006) Oxidant and carbonyl stress-

Borregaard N, Miller LJ, Springer TA (1987) Chemoattractant-regulated mobilization of a

Brogden, K. A. and J. M. Guthmiller (2002) The Host Response: A Double-edged Sword.

Canaud B, Chenine L, Henriet D, Leray H (2008) Cross-membrane flux is a major factor

Canaud B, Bragg-Gresham JL, Marshall MR, Desmeules S, Gillespie BW et al. (2006)

Carracedo J, Ramirez R, Madueno JA, Soriano S, Rodriguez-Benot A et al. (2002) Cell apoptosis and hemodialysis-induced inflammation. *Kidney Int Suppl*(80): 89-93. Carrero JJ, Yilmaz MI, Lindholm B, Stenvinkel P (2008) Cytokine dysregulation in chronic

Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in

Chauveau P, Nguyen H, Combe C, Chene G, Azar R et al. (2005) Dialyzer membrane permeability and survival in hemodialysis patients. *Am J Kidney Dis* 45(3): 565-571. Cheung AK, Parker CJ, Wilcox L, Janatova J (1989) Activation of the alternative pathway of complement by cellulosic hemodialysis membranes. *Kidney Int* 36(2): 257-265. Cheung AK, Greene T, Leypoldt JK, Yan G, Allon M et al. (2008) Association between serum

Cheung AK, Levin NW, Greene T, Agodoa L, Bailey J et al. (2003) Effects of high-flux

Chuluyan HE, Issekutz AC (1993) VLA-4 integrin can mediate CD11/CD18-independent transendothelial migration of human monocytes. *J Clin Invest* 92(6): 2768-2777.

2-microglobulin level and infectious mortality in hemodialysis patients. *Clin J Am* 

hemodialysis on clinical outcomes: results of the HEMO study. *J Am Soc Nephrol*

influencing dialysis patient outcomes. *Contrib Nephrol* 161: 178-184.

European results from the DOPPS. *Kidney Int* 69(11): 2087-2093.

kidney disease: how can we treat it? *Blood Purif* 26(3): 291-299.

membrane on infection-related hospitalization and death: results of the HEMO

stored in peroxidase-negative granules of human neutrophils. *J Exp Med* 166(6):

related apoptosis in end-stage kidney disease: impact of membrane flux. *Blood Purif* 

novel intracellular compartment in human neutrophils. *Science* 237(4819): 1204-

Mortality risk for patients receiving hemodiafiltration versus hemodialysis:

Alberts, B., A. Johnson, et al. (2002) *Molecular Biology of the Cell*. New York.

Babior BM (1999) NADPH oxidase: an update. *Blood* 93(5): 1464-1476.

dialysis patients. *Adv Ren Replace Ther* 3(3): 201-207.

*Polymicrobial diseases*. Herndon, VA, ASM Press.

inflammation. *N Engl J Med* 354(6): 610-621.

*Soc Nephrol* 3(1): 69-77.

14(12): 3251-3263.

Study. *J Am Soc Nephrol* 14(7): 1863-1870.

*Lancet* 349(9050): 490-495.

*Faseb J* 8(8): 504-512.

1641-1653.

24(1): 149-156.

1206.


Jiang, Y., D. I. Beller, et al. (1992) Monocyte chemoattractant protein-1 regulates adhesion

Jiang, Y., J. F. Zhu, et al. (1994) MCP-1-stimulated monocyte attachment to laminin is

Johnson-Leger C, Aurrand-Lions M, Imhof BA (2000) The parting of the endothelium:

Johnson F, Giulivi C (2005) Superoxide dismutases and their impact upon human health.

Kaysen GA (2001) The microinflammatory state in uremia: causes and potential

Kaysen GA, Kumar V (2003) Inflammation in ESRD: causes and potential consequences. *J* 

Kobayashi Y (2008) The role of chemokines in neutrophil biology. *Front Biosci* 13: 2400-2407. Koller H, Hochegger K, Zlabinger GJ, Lhotta K, Mayer G et al. (2004) Apoptosis of human

Ledebo I (1998) Principles and practice of hemofiltration and hemodiafiltration. *Artif Organs*

Liu, G., Y. J. Park, et al. (2008). Interleukin-1 receptor-associated kinase (IRAK) -1-mediated

Locatelli F (2003) Dose of dialysis, convection and haemodialysis patients outcome--what

Locatelli F, Martin-Malo A, Hannedouche T, Loureiro A, Papadimitriou M et al. (2009) Effect

Lundberg L, Johansson G, Karlsson L, Stegmayr BG (1994) Complement activation is

Malaponte G, Libra M, Bevelacqua Y, Merito P, Fatuzzo P et al. (2007) Inflammatory status

Martin-Malo A, Carracedo J, Ramirez R, Rodriguez-Benot A, Soriano S et al. (2000) Effect of

Miller LJ, Bainton DF, Borregaard N, Springer TA (1987) Stimulated mobilization of

Moshfegh A, Jacobson SH, Hallden G, Thylen P, Lundahl J (2002) Impact of hemodialysis

and type of dialysate. *Nephrol Dial Transplant* 9(9): 1310-1314.

compartment to the cell surface. *J Clin Invest* 80(2): 535-544.

cytokines. *Int J Mol Med* 20(4): 471-481.

polymorphonuclear neutrophils accelerated by dialysis membranes via the activation of the complement system. *Nephrol Dial Transplant* 19(12): 3104-3111. Kosch M, Levers A, Fobker M, Barenbrock M, Schaefer RM et al. (2003) Dialysis filter type

determines the acute effect of haemodialysis on endothelial function and oxidative

NF-kappaB activation requires cytosolic and nuclear activity. *Faseb J* 22(7): 2285-96.

the HEMO study doesn't tell us: the European viewpoint. *Nephrol Dial Transplant*

of membrane permeability on survival of hemodialysis patients. *J Am Soc Nephrol*

influenced by the membrane material, design of the dialyser, sterilizing method,

in patients with chronic renal failure: the role of PTX3 and pro-inflammatory

uremia and dialysis modality on mononuclear cell apoptosis. *J Am Soc Nephrol*

monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular

membrane and permeability on neutrophil transmigration in vitro. *Nephron* 91(4):

mediated by beta 2-integrins. *Am J Physiol* 267(4 Pt 1): C1112-8.

miracle, or simply a junctional affair? *J Cell Sci* 113 (Pt 6): 921-933.

148(8): 2423-8.

*Mol Aspects Med* 26(4-5): 340-352.

*Ren Nutr* 13(2): 158-160.

22(1): 20-25.

18(6): 1061-1065.

20(3): 645-654.

11(5): 936-942.

659-665.

consequences. *J Am Soc Nephrol* 12(7): 1549-1557.

stress. *Nephrol Dial Transplant* 18(7): 1370-1375.

molecule expression and cytokine production in human monocytes. *J Immunol*


Follin P (1999) Skin chamber technique for study of in vivo exudated human neutrophils. *J* 

Gibbons RA, Martinez OM, Garovoy MR (1990) Altered monocyte function in uremia. *Clin* 

Gonzalez-Amaro R, Sanchez-Madrid F (1999) Cell adhesion molecules: selectins and

Graff LR, Franklin KK, Witt L, Cohen N, Jacobs RA et al. (2002) Antimicrobial therapy of

Haag-Weber M, Horl WH (1996a) Are granulocyte inhibitory proteins contributing to

Haag-Weber M, Horl WH (1996b) Dysfunction of polymorphonuclear leukocytes in uremia.

Haag-Weber M, Hable M, Fiedler G, Blum I, Schollmeyer P et al. (1991) Alterations of

Hermant B, Bibert S, Concord E, Dublet B, Weidenhaupt M et al. (2003) Identification of

Hernandez MR, Galan AM, Cases A, Lopez-Pedret J, Pereira A et al. (2004) Biocompatibility

Himmelfarb J, Lazarus JM, Hakim R (1991) Reactive oxygen species production by

Himmelfarb J, Ault KA, Holbrook D, Leeber DA, Hakim RM (1993) Intradialytic granulocyte

Horl WH (2001) Neutrophil function in renal failure. *Adv Nephrol Necker Hosp* 31: 173-192. Horl WH (2002) Hemodialysis membranes: interleukins, biocompatibility, and middle

Hornberger JC, Chernew M, Petersen J, Garber AM (1992) A multivariate analysis of

Idriss, H. T. and J. H. Naismith (2000) TNF alpha and the TNF receptor superfamily:

Ikeda, U., K. Matsui, et al. (2002) Monocyte chemoattractant protein-1 and coronary artery

Jacobson SH, Thylen P, Lundahl J (2000) Three monocyte-related determinants of atherosclerosis in haemodialysis. *Nephrol Dial Transplant* 15(9): 1414-1419. Jacobson SH, Thylen P, Fernvik E, Hallden G, Gronneberg R et al. (2002) Hemodialysis-

structure-function relationship(s). *Microsc Res Tech* 50(3): 184-95.

Janeway C, Travers P (2005) *Immunobiology*. New York: Garland Publisher.

neutrophil transmigration. *J Biol Chem* 278(16): 14002-14012.

gram-negative bacteremia at two university-affiliated medical centers. *Am J Med* 

enhanced susceptibility to infections in uraemia? *Nephrol Dial Transplant* 11 Suppl 2:

polymorphonuclear leukocyte glycogen metabolism and glucose uptake in dialysis

proteases involved in the proteolysis of vascular endothelium cadherin during

of cellulosic and synthetic membranes assessed by leukocyte activation. *Am J* 

monocytes and polymorphonuclear leukocytes during dialysis. *Am J Kidney Dis*

reactive oxygen species production: a prospective, crossover trial. *J Am Soc Nephrol*

mortality and hospital admissions with high-flux dialysis. *J Am Soc Nephrol* 3(6):

activated granulocytes at the site of interstitial inflammation. *Am J Kidney Dis* 39(4):

*Immunol Methods* 232(1-2): 55-65.

*Semin Nephrol* 16(3): 192-201.

*Nephrol* 24(2): 235-241.

17(3): 271-276.

4(2): 178-186.

1227-1237.

854-861.

patients. *Am J Kidney Dis* 17(5): 562-568.

molecules. *J Am Soc Nephrol* 13 Suppl 1: S62-71.

disease. *Clin Cardiol* 25(4): 143-7.

112(3): 204-211.

98-100.

*Immunol Immunopathol* 56(1): 66-80.

integrins. *Crit Rev Immunol* 19(5-6): 389-429.


Sardenberg C, Suassuna P, Andreoli MC, Watanabe R, Dalboni MA et al. (2006) Effects of

Sarnak MJ, Jaber BL (2000) Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. *Kidney Int* 58(4): 1758-1764. Scheja A, Forsgren A (1985) A skin chamber technique for leukocyte migration studies; description and reproducibility. *Acta Pathol Microbiol Immunol Scand* 93: 25-30. Schindler R, Eichert F, Lepenies J, Frei U (2001) Blood components influence cytokine

Schindler R, Ertl T, Beck W, Lepenies J, Boenisch O et al. (2006) Reduced cytokine induction

Sela S, Shurtz-Swirski R, Cohen-Mazor M, Mazor R, Chezar J et al. (2005) Primed peripheral

Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J (2000) Are there two

Swain SD, Rohn TT, Quinn MT (2002) Neutrophil priming in host defense: role of oxidants

Theilgaard-Monch K, Porse BT, Borregaard N (2006) Systems biology of neutrophil differentiation and immune response. *Curr Opin Immunol* 18(1): 54-60. Theilgaard-Monch K, Knudsen S, Follin P, Borregaard N (2004) The transcriptional

Thylen P, Fernvik E, Haegerstrand A, Lundahl J, Jacobson SH (1997) Dialysis-induced

Thylen P, Lundahl J, Fernvik E, Gronneberg R, Hallden G et al. (2000) Impaired monocyte

van Buul JD, Hordijk PL (2004) Signaling in leukocyte transendothelial migration.

Van Den Steen, P. E., A. Wuyts, et al. (2003) Gelatinase B/MMP-9 and neutrophil

Vanholder R, Van Biesen W, Ringoir S (1993a) Contributing factors to the inhibition of

Vanholder R, De Smet R, Hsu C, Vogeleere P, Ringoir S (1994a) Uremic toxicity: the middle

Vanholder R, Van Loo A, Dhondt AM, De Smet R, Ringoir S (1996) Influence of uraemia and

haemodialysis on host defence and infection. *Nephrol Dial Transplant* 11(4): 593-598.

phagocytosis in hemodialyzed patients. *Kidney Int* 44(1): 208-214.

molecule hypothesis revisited. *Semin Nephrol* 14(3): 205-218.

and removal of complement products with synthetic hemodialysis membranes.

polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. *J Am Soc* 

types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). *Nephrol Dial* 

activation program of human neutrophils in skin lesions supports their important

serum factors inhibit adherence of monocytes and granulocytes to adult human

CD11b expression in interstitial inflammation in hemodialysis patients. *Kidney Int*

collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. *Eur* 

induction by bacterial substances. *Blood Purif* 19(4): 380-387.

as priming agents. *Antioxid Redox Signal* 4(1): 69-83.

role in wound healing. *J Immunol* 172(12): 7684-7693.

endothelial cells. *Am J Kidney Dis* 29(1): 78-85.

*Arterioscler Thromb Vasc Biol* 24(5): 824-833.

*Nephrol Dial Transplant* 21(1): 160-165.

*Blood Purif* 24(2): 203-211.

*Nephrol* 16(8): 2431-2438.

*Transplant* 15(7): 953-960.

57(5): 2099-2106.

*J Biochem* 270(18): 3739-49.

uraemia and dialysis modality on polymorphonuclear cell apoptosis and function.


Muniz-Junqueira MI, Braga Lopes C, Magalhaes CA, Schleicher CC, Veiga JP (2005) Acute

Olsson J, Paulsson J, Dadfar E, Lundahl J, Moshfegh A et al. (2009) Monocyte and neutrophil

Parkin J, Cohen B (2001) An overview of the immune system. *Lancet* 357(9270): 1777-1789. Paulsson J, Dadfar E, Held C, Jacobson SH, Lundahl J (2007) Activation of peripheral and in

Panichi, V., U. Maggiore, et al. (2004) Interleukin-6 is a stronger predictor of total and

Pawlak K, Naumnik B, Brzosko S, Pawlak D, Mysliwiec M (2004) Oxidative stress - a link

Pecoits-Filho, R., P. Barany, et al. (2002) Interleukin-6 is an independent predictor of

Pecoits-Filho R, Lindholm B, Stenvinkel P (2002) The malnutrition, inflammation, and

Powe NR, Jaar B, Furth SL, Hermann J, Briggs W (1999) Septicemia in dialysis patients:

Pupim, L. B., J. Himmelfarb, et al. (2004) Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress. *Kidney Int* 65(6): 2371-9. Rabindranath KS, Strippoli GF, Daly C, Roderick PJ, Wallace S et al. (2006)

Raj DS, Vincent B, Simpson K, Sato E, Jones KL et al. (2002) Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin. *Kidney Int* 61(2): 697-704. Ramos, C. D., C. Canetti, et al. (2005) MIP-1alpha[CCL3] acting on the CCR1 receptor

Rezzonico, R., V. Imbert, et al. (2001) Ligation of CD11b and CD11c beta(2) integrins by

pathway dependent on nuclear factor-kappaB. *Blood* 97(10): 2932-40. Rocco MV, Cheung AK, Greene T, Eknoyan G (2005) The HEMO Study: applicability and

incidence, risk factors, and prognosis. *Kidney Int* 55(3): 1081-1090.

production in chronic renal failure patients. *Life Sci* 77(25): 3141-3155. Olsson J, Dadfar E, Paulsson J, Lundahl J, Moshfegh A et al. (2007) Preserved leukocyte

hemodialysis or hemodiafiltration. *Blood Purif* 28(1): 47-52.

haemodialysis patients. *Am J Nephrol* 24(1): 154-161.

disease. *Cochrane Database Syst Rev*(4): CD006258.

TNF-alpha and LTB4. *J Leukoc Biol* 78(1): 167-77.

generalizability. *Nephrol Dial Transplant* 20(2): 278-284.

hemodiafiltration. *Kidney Int* 71(6): 582-588.

*Atherosclerosi*s 192(2): 328-334.

*Dial Transplant* 19(5): 1154-60.

8.

17 Suppl 11: 28-31.

and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines

CD11b expression at the site of interstitial inflammation in patients with high-flux

chemotactic activity at the site of interstitial inflammation in patients on high-flux

vivo transmigrated neutrophils in patients with stable coronary artery disease.

cardiovascular mortality than C-reactive protein in haemodialysis patients. *Nephrol* 

between endothelial injury, coagulation activation, and atherosclerosis in

mortality in patients starting dialysis treatment. *Nephrol Dial Transplant* 17(9): 1684-

atherosclerosis (MIA) syndrome -- the heart of the matter. *Nephrol Dial Transplant*

Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney

mediates neutrophil migration in immune inflammation via sequential release of

antibodies or soluble CD23 induces macrophage inflammatory protein 1alpha (MIP-1alpha) and MIP-1beta production in primary human monocytes through a


**10** 

*United States* 

**Dialysis Membrane Manipulation** 

Michael Henrie, Cheryl Ford, Eric Stroup and Chih-Hu Ho

In the dialysis clinic, water is an essential vehicle to deliver life-saving treatment to patients suffering from varying degrees of kidney failure, both acute and chronic. Clean water is vital, as the key ingredient used to prepare hemodialysis fluid (dialysate solution), and online generation of substitution fluid for hemodiafiltration. Generally all fluids used to treat patients suffering from kidney failure may come into contact with the blood of the patient, whether directly or indirectly (across a membrane), and theoretically could transport contaminants resulting in a negative impact on patient health. Of the microbiological contaminants found in water, endotoxin is given considerable attention, given its difficulty for removal and inactivation from water and water distribution systems (Smeets et al., 2003; Perez-Garcia & Rodriguez-Benitez, 2000) and its inherent pyrogenicity (G. Lonnemann,

Endotoxins are found in all gram-negative bacteria, although slight differences in chemical structure are found between varying bacterial strains. The term endotoxin is typically used to describe a complex of protein and lipopolysaccharide (LPS) molecules found in the outer cell wall of gram-negative bacteria, that either slough off during growth, or are released upon cell lysis. Endotoxin and lipopolysaccharide are typically used interchangeably in literature, although in clinical discussion the term endotoxin is most often used, as it is the metric used to monitor water and dialysis fluid quality. Lipopolysaccharide is a vital component of the outer membrane of gram-negative bacteria, providing numerous physiological functions and comprising nearly 75% of the bacterium outer surface area (Raetz, 1991). Lipopolysaccharides consist of three components: a long heteropolysaccharide chain (O-specific chain) which represents a surface antigen; a core oligosaccharide; and a lipid component termed lipid A used as an anchor in the outer cell membrane (Rietschel et al., 1994; Gorbet & Sefton, 2005). Molecular weights of most lipopolysaccharides are 10 – 20 kDa; however, due to their amphiphilic nature, LPS molecules can form aggregates (100 – 1000 kDa) which are too large to pass through dialysis membranes. It has been shown that components of lipopolysaccharide (lipid A) are able to pass through dialysis membranes, can elicit a pyrogenic response (Naveh-Many et al., 1999), and contribute to long-term

Lipid A is the most conserved component of lipopolysaccharide throughout all gramnegative bacteria, and as such is responsible for the majority of the pyrogenic activity. Lipid A consists of a phosphorylated N-acetylglucosamine (NAG) dimmer connected to saturated

morbidity and inflammation (H. Schiffl, 2000; Raj et al., 2009).

**1. Introduction** 

2000).

**for Endotoxin Removal** 

*Fresenius Medical Care North America* 

